Journal: Medical Microbiology and Immunology

Article Title: Bacterial aggregate size determines phagocytosis efficiency of polymorphonuclear leukocytes

doi: 10.1007/s00430-020-00691-1

Figure Lengend Snippet: Bacterial strains used in this study

Article Snippet: P. aeruginosa (PAO1) obtained from the Pseudomonas Genetic Stock Center ( www.ecu.edu/pseudomonas ; strain PAO0001), S. epidermidis from a nose (ATCC 14990;(HUGH und ELLIS 1968)), a E. coli from a child with diarrhoea (042) [ ] and S. aureus strain NCTC 8325 named S. aureus 8325–4 were used [ ].

Techniques:

Journal:

Article Title: Identification of RNase 8 as a Novel Human Antimicrobial Protein

doi: 10.1128/AAC.00246-06

Figure Lengend Snippet: Antimicrobial activity of RNase 8 against various clinically relevant microorganisms

Article Snippet: An LD 90 value of 0.1 μM for both Pseudomonas aeruginosa and Staphylococcus aureus indicates a slightly higher activity of RNase 7 compared to RNase 8. table ft1 table-wrap mode="anchored" t5 caption a7 Strain a MBC b (μM) LD 90 (μM) Gram-positive strains Staphylococcus aureus ATCC 6538 1.8 0.9 Staphylococcus aureus ATCC 12600 1.8 0.4 Staphylococcus aureus ATCC 33593 (MRSA) 1.8 0.4 Staphylococcus aureus ATCC 43300 (MRSA) 0.9 0.2-0.4 Staphylococcus epidermidis ATCC 14990 0.9-1.8 0.4-0.9 Streptococcus pyogenes ATCC 12344 0.9-3.5 0.2-0.4 Streptococcus pneumoniae ATCC 33400 >7.0 3.5-7.0 Enterococcus faecalis ATCC 29212 0.4-1.8 0.2 Enterococcus faecalis ATCC 51299 (VRE) 3.5 0.2-0.4 Enterococcus faecium DSM 2146 0.4 0.2 Enterococcus faecium clinical isolate (VRE) 0.4 0.2 Enterococcus faecium clinical isolate (VRE) >7.0 0.2 Enterococcus faecium clinical isolate 0.4 0.2-0.4 Gram-negative strains Escherichia coli ATCC 25922 0.2-0.9 0.1-0.2 Escherichia coli ATCC 35218 0.2 0.1 Escherichia coli ATCC 11775 0.4 0.1-0.4 Klebsiella pneumoniae ATCC 13882 0.2-0.9 0.1-0.4 Klebsiella pneumoniae ATCC 13883 0.1-0.2 0.1 Enterobacter cloacae ATCC 13047 7.0 0.4 Serratia marcescens NCTC 10211 >7.0 >7.0 Citrobacter freundii NCTC 9750 >7.0 0.4-3.5 Pseudomonas aeruginosa ATCC 10145 0.4-0.9 0.2-0.4 Pseudomonas aeruginosa clinical isolate 0.2 0.1 Pseudomonas fluorescens NCTC 10038 >7.0 0.9-1.8 Burkholderia cepacia ATCC 25416 >7.0 >7.0 Acinetobacter baumannii ATCC 19606 0.2 0.1 Fungus, Candida albicans ATCC 24433 1.8 0.2 Open in a separate window a MRSA, methicillin-resistant Staphylococcus aureus ; VRE, vancomycin-resistant enterococci. b MBC, minimal bactericidal concentration.

Techniques: Activity Assay

Journal: Molecules

Article Title: Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand

doi: 10.3390/molecules28030996

Figure Lengend Snippet: Antibacterial activity of royal jelly samples against skin pathogenic bacteria by an agar well diffusion assay.

Article Snippet: Skin pathogenic bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) 49, Pseudomonas aeruginosa ATCC 27,853, S. aureus ATCC 25,923, S. epidermidis ATCC 14,990 and Corynebacterium spp., were cultured on Mueller–Hinton agar (MHA) at 37 °C for 18–24 h. Cutibacterium acnes DMST 14,916 was cultured on Brain Heart Infusion agar (BHIA) at 37 °C for 48–72 h in anaerobic conditions.

Techniques: Activity Assay, Bacteria, Diffusion-based Assay, Inhibition, Control

Journal: Molecules

Article Title: Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand

doi: 10.3390/molecules28030996

Figure Lengend Snippet: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the royal jelly samples against skin pathogenic bacteria.

Article Snippet: Skin pathogenic bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) 49, Pseudomonas aeruginosa ATCC 27,853, S. aureus ATCC 25,923, S. epidermidis ATCC 14,990 and Corynebacterium spp., were cultured on Mueller–Hinton agar (MHA) at 37 °C for 18–24 h. Cutibacterium acnes DMST 14,916 was cultured on Brain Heart Infusion agar (BHIA) at 37 °C for 48–72 h in anaerobic conditions.

Techniques: Concentration Assay, Bacteria, Control